Global Antibody Library Technologies
Global Antibody Library Technologies

Antibody Library Technologies Comprehensive Study by End-users (Biopharmaceutical Companies, Contract Research Organization, Academic & Research Institutes), Technology (Phage Display, Ribosome Display, Yeast Display, Mammalian Cell Surface Display), Combinatorial Antibody Libraries (Naïve, Immune, Semi-synthetic, Synthetic libraries) Players and Region - Global Market Outlook to 2027

Antibody Library Technologies Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Mar 2022 Edition 213 Pages 57 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Antibody Library Technologies?
Antibody library science presents in vitro technique for the era of surprisingly specific, recombinant, humanized or absolutely human monoclonal antibodies, which can be used for preferred goal screening. Immune antibody library is developed from B-cells of immunized or contaminated humans towards a unique antigen of interest. Upon publicity to the antigen, in vivo affinity maturation and V gene hypermutation helps structure a precise repertoire towards the antigen. Antibody libraries are, as the identify suggests, libraries of present antibodies that can be searched to grant these that may want to be high-quality towards a pathogen. A frequently used science in antibody libraries is phage display, the place genetically manipulated bacteriophages with antibodies on their surfaces bind to the immobilized antigen.

The market study is broken down and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Antibody Library Technologies market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Abzena Plc. (United States), XOMA Corporation (United States), AvantGen Inc. (United States), Creative-biolabs (United States), Philogen S.p.A. (Italy), Adimab LLC (United States), Invenra Inc. (United States), AnaptysBio, Inc. (United States), Abgent Inc. (WuXi AppTec company) (United States) and Vaccinex Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are AxioMx Inc. (United States).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Antibody Library Technologies market by Type, Application and Region.

On the basis of geography, the market of Antibody Library Technologies has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Biopharmaceutical Companies will boost the Antibody Library Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Technology, the sub-segment i.e. Phage Display will boost the Antibody Library Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Combinatorial Antibody Libraries , the sub-segment i.e. Naïve will boost the Antibody Library Technologies market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
In 2020, Adimab LLC extended its partnership with Novo Nordisk related to the Adimab Platform license agreement, aiming at the discovery and optimization of antibody-based protein therapeutics.



Market Trend
  • Increasing Prevalence of rare diseases
  • Rising Awareness about Immunotherapy in developed Countries

Market Drivers
  • Increasing Prevalence of Chronic Diseases
  • Rise in Need for Immunotherapy

Opportunities
  • Rising Healthcare Expenditure
  • Rising Research and Development activities of Antibody Library Technologies

Restraints
  • High Cost Associated with Technologies
  • Lack of skilled Labor


Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Abzena Plc. (United States), XOMA Corporation (United States), AvantGen Inc. (United States), Creative-biolabs (United States), Philogen S.p.A. (Italy), Adimab LLC (United States), Invenra Inc. (United States), AnaptysBio, Inc. (United States), Abgent Inc. (WuXi AppTec company) (United States) and Vaccinex Inc. (United States) etc.

2. Can we have customized study for Antibody Library Technologies Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Antibody Library Technologies Market by 2027?
Analysts at AMA estimates Antibody Library Technologies Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By End-users
  • Biopharmaceutical Companies
  • Contract Research Organization
  • Academic & Research Institutes

By Technology
  • Phage Display
  • Ribosome Display
  • Yeast Display
  • Mammalian Cell Surface Display

By Combinatorial Antibody Libraries
  • Naïve
  • Immune
  • Semi-synthetic
  • Synthetic libraries

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Chronic Diseases
      • 3.2.2. Rise in Need for Immunotherapy
    • 3.3. Market Trends
      • 3.3.1. Increasing Prevalence of rare diseases
      • 3.3.2. Rising Awareness about Immunotherapy in developed Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Library Technologies, by End-users, Technology, Combinatorial Antibody Libraries and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Antibody Library Technologies (Value)
      • 5.2.1. Global Antibody Library Technologies by: End-users (Value)
        • 5.2.1.1. Biopharmaceutical Companies
        • 5.2.1.2. Contract Research Organization
        • 5.2.1.3. Academic & Research Institutes
      • 5.2.2. Global Antibody Library Technologies by: Technology (Value)
        • 5.2.2.1. Phage Display
        • 5.2.2.2. Ribosome Display
        • 5.2.2.3. Yeast Display
        • 5.2.2.4. Mammalian Cell Surface Display
      • 5.2.3. Global Antibody Library Technologies Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Antibody Library Technologies: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abzena Plc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. XOMA Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. AvantGen Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Creative-biolabs (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Philogen S.p.A. (Italy)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Adimab LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Invenra Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AnaptysBio, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Abgent Inc. (WuXi AppTec company) (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vaccinex Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antibody Library Technologies Sale, by End-users, Technology, Combinatorial Antibody Libraries and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Antibody Library Technologies (Value)
      • 7.2.1. Global Antibody Library Technologies by: End-users (Value)
        • 7.2.1.1. Biopharmaceutical Companies
        • 7.2.1.2. Contract Research Organization
        • 7.2.1.3. Academic & Research Institutes
      • 7.2.2. Global Antibody Library Technologies by: Technology (Value)
        • 7.2.2.1. Phage Display
        • 7.2.2.2. Ribosome Display
        • 7.2.2.3. Yeast Display
        • 7.2.2.4. Mammalian Cell Surface Display
      • 7.2.3. Global Antibody Library Technologies Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Library Technologies: by End-users(USD Million)
  • Table 2. Antibody Library Technologies Biopharmaceutical Companies , by Region USD Million (2016-2021)
  • Table 3. Antibody Library Technologies Contract Research Organization , by Region USD Million (2016-2021)
  • Table 4. Antibody Library Technologies Academic & Research Institutes , by Region USD Million (2016-2021)
  • Table 5. Antibody Library Technologies: by Technology(USD Million)
  • Table 6. Antibody Library Technologies Phage Display , by Region USD Million (2016-2021)
  • Table 7. Antibody Library Technologies Ribosome Display , by Region USD Million (2016-2021)
  • Table 8. Antibody Library Technologies Yeast Display , by Region USD Million (2016-2021)
  • Table 9. Antibody Library Technologies Mammalian Cell Surface Display , by Region USD Million (2016-2021)
  • Table 10. South America Antibody Library Technologies, by Country USD Million (2016-2021)
  • Table 11. South America Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 12. South America Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 13. South America Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 14. Brazil Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 15. Brazil Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 16. Brazil Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 17. Argentina Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 18. Argentina Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 19. Argentina Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 20. Rest of South America Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 21. Rest of South America Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 22. Rest of South America Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 23. Asia Pacific Antibody Library Technologies, by Country USD Million (2016-2021)
  • Table 24. Asia Pacific Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 25. Asia Pacific Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 26. Asia Pacific Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 27. China Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 28. China Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 29. China Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 30. Japan Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 31. Japan Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 32. Japan Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 33. India Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 34. India Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 35. India Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 36. South Korea Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 37. South Korea Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 38. South Korea Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 39. Taiwan Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 40. Taiwan Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 41. Taiwan Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 42. Australia Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 43. Australia Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 44. Australia Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 45. Rest of Asia-Pacific Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 46. Rest of Asia-Pacific Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 47. Rest of Asia-Pacific Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 48. Europe Antibody Library Technologies, by Country USD Million (2016-2021)
  • Table 49. Europe Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 50. Europe Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 51. Europe Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 52. Germany Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 53. Germany Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 54. Germany Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 55. France Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 56. France Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 57. France Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 58. Italy Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 59. Italy Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 60. Italy Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 61. United Kingdom Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 62. United Kingdom Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 63. United Kingdom Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 64. Netherlands Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 65. Netherlands Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 66. Netherlands Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 67. Rest of Europe Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 68. Rest of Europe Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 69. Rest of Europe Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 70. MEA Antibody Library Technologies, by Country USD Million (2016-2021)
  • Table 71. MEA Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 72. MEA Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 73. MEA Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 74. Middle East Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 75. Middle East Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 76. Middle East Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 77. Africa Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 78. Africa Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 79. Africa Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 80. North America Antibody Library Technologies, by Country USD Million (2016-2021)
  • Table 81. North America Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 82. North America Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 83. North America Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 84. United States Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 85. United States Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 86. United States Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 87. Canada Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 88. Canada Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 89. Canada Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 90. Mexico Antibody Library Technologies, by End-users USD Million (2016-2021)
  • Table 91. Mexico Antibody Library Technologies, by Technology USD Million (2016-2021)
  • Table 92. Mexico Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2016-2021)
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Antibody Library Technologies: by End-users(USD Million)
  • Table 104. Antibody Library Technologies Biopharmaceutical Companies , by Region USD Million (2022-2027)
  • Table 105. Antibody Library Technologies Contract Research Organization , by Region USD Million (2022-2027)
  • Table 106. Antibody Library Technologies Academic & Research Institutes , by Region USD Million (2022-2027)
  • Table 107. Antibody Library Technologies: by Technology(USD Million)
  • Table 108. Antibody Library Technologies Phage Display , by Region USD Million (2022-2027)
  • Table 109. Antibody Library Technologies Ribosome Display , by Region USD Million (2022-2027)
  • Table 110. Antibody Library Technologies Yeast Display , by Region USD Million (2022-2027)
  • Table 111. Antibody Library Technologies Mammalian Cell Surface Display , by Region USD Million (2022-2027)
  • Table 112. South America Antibody Library Technologies, by Country USD Million (2022-2027)
  • Table 113. South America Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 114. South America Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 115. South America Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 116. Brazil Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 117. Brazil Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 118. Brazil Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 119. Argentina Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 120. Argentina Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 121. Argentina Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 122. Rest of South America Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 123. Rest of South America Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 124. Rest of South America Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 125. Asia Pacific Antibody Library Technologies, by Country USD Million (2022-2027)
  • Table 126. Asia Pacific Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 127. Asia Pacific Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 128. Asia Pacific Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 129. China Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 130. China Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 131. China Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 132. Japan Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 133. Japan Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 134. Japan Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 135. India Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 136. India Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 137. India Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 138. South Korea Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 139. South Korea Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 140. South Korea Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 141. Taiwan Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 142. Taiwan Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 143. Taiwan Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 144. Australia Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 145. Australia Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 146. Australia Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 147. Rest of Asia-Pacific Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 148. Rest of Asia-Pacific Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 149. Rest of Asia-Pacific Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 150. Europe Antibody Library Technologies, by Country USD Million (2022-2027)
  • Table 151. Europe Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 152. Europe Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 153. Europe Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 154. Germany Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 155. Germany Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 156. Germany Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 157. France Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 158. France Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 159. France Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 160. Italy Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 161. Italy Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 162. Italy Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 163. United Kingdom Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 164. United Kingdom Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 165. United Kingdom Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 166. Netherlands Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 167. Netherlands Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 168. Netherlands Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 169. Rest of Europe Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 170. Rest of Europe Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 171. Rest of Europe Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 172. MEA Antibody Library Technologies, by Country USD Million (2022-2027)
  • Table 173. MEA Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 174. MEA Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 175. MEA Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 176. Middle East Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 177. Middle East Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 178. Middle East Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 179. Africa Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 180. Africa Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 181. Africa Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 182. North America Antibody Library Technologies, by Country USD Million (2022-2027)
  • Table 183. North America Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 184. North America Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 185. North America Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 186. United States Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 187. United States Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 188. United States Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 189. Canada Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 190. Canada Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 191. Canada Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 192. Mexico Antibody Library Technologies, by End-users USD Million (2022-2027)
  • Table 193. Mexico Antibody Library Technologies, by Technology USD Million (2022-2027)
  • Table 194. Mexico Antibody Library Technologies, by Combinatorial Antibody Libraries USD Million (2022-2027)
  • Table 195. Research Programs/Design for This Report
  • Table 196. Key Data Information from Secondary Sources
  • Table 197. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Library Technologies: by End-users USD Million (2016-2021)
  • Figure 5. Global Antibody Library Technologies: by Technology USD Million (2016-2021)
  • Figure 6. South America Antibody Library Technologies Share (%), by Country
  • Figure 7. Asia Pacific Antibody Library Technologies Share (%), by Country
  • Figure 8. Europe Antibody Library Technologies Share (%), by Country
  • Figure 9. MEA Antibody Library Technologies Share (%), by Country
  • Figure 10. North America Antibody Library Technologies Share (%), by Country
  • Figure 11. Global Antibody Library Technologies share by Players 2021 (%)
  • Figure 12. Global Antibody Library Technologies share by Players (Top 3) 2021(%)
  • Figure 13. Global Antibody Library Technologies share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abzena Plc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abzena Plc. (United States) Revenue: by Geography 2021
  • Figure 17. XOMA Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. XOMA Corporation (United States) Revenue: by Geography 2021
  • Figure 19. AvantGen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. AvantGen Inc. (United States) Revenue: by Geography 2021
  • Figure 21. Creative-biolabs (United States) Revenue, Net Income and Gross profit
  • Figure 22. Creative-biolabs (United States) Revenue: by Geography 2021
  • Figure 23. Philogen S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 24. Philogen S.p.A. (Italy) Revenue: by Geography 2021
  • Figure 25. Adimab LLC (United States) Revenue, Net Income and Gross profit
  • Figure 26. Adimab LLC (United States) Revenue: by Geography 2021
  • Figure 27. Invenra Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Invenra Inc. (United States) Revenue: by Geography 2021
  • Figure 29. AnaptysBio, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. AnaptysBio, Inc. (United States) Revenue: by Geography 2021
  • Figure 31. Abgent Inc. (WuXi AppTec company) (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abgent Inc. (WuXi AppTec company) (United States) Revenue: by Geography 2021
  • Figure 33. Vaccinex Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Vaccinex Inc. (United States) Revenue: by Geography 2021
  • Figure 35. Global Antibody Library Technologies: by End-users USD Million (2022-2027)
  • Figure 36. Global Antibody Library Technologies: by Technology USD Million (2022-2027)
  • Figure 37. South America Antibody Library Technologies Share (%), by Country
  • Figure 38. Asia Pacific Antibody Library Technologies Share (%), by Country
  • Figure 39. Europe Antibody Library Technologies Share (%), by Country
  • Figure 40. MEA Antibody Library Technologies Share (%), by Country
  • Figure 41. North America Antibody Library Technologies Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abzena Plc. (United States)
  • XOMA Corporation (United States)
  • AvantGen Inc. (United States)
  • Creative-biolabs (United States)
  • Philogen S.p.A. (Italy)
  • Adimab LLC (United States)
  • Invenra Inc. (United States)
  • AnaptysBio, Inc. (United States)
  • Abgent Inc. (WuXi AppTec company) (United States)
  • Vaccinex Inc. (United States)
Additional players considered in the study are as follows:
AxioMx Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation